Public Comments

Publish Date
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Public Comments
C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011)
Public Comments
C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program
Public Comments
C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048)
Public Comments
Written Submission on Inv. No. 337-TA-1380

Dear Mr. Needham, The Council for Innovation Promotion (C4IP) submits this response to the Commission’s February 27, 2025, request for written submissions...

Public Comments
C4IP Written Submission RE: Inv. No. 337-TA-1380
Public Comments
C4IP Comments RE: The Development of an Artificial Intelligence (AI) Action Plan (2025-02305)
Public Comments
Joint High-Level Statement Valuing Creation, Invention, and Innovation: Re-booting Europe’s Potential
Public Comments
C4IP Comments RE: Experimental Use Exception Request for Comments (PTO-C-2024-0023)
Public Comments
C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026)
Resources:

Resources:

C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime,

11/06/2025

Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025

Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Resources:

Resources:

C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048),

03/18/2025

Resources:

Resources:

Written Submission on Inv. No. 337-TA-1380,

03/13/2025

Resources:

Resources:

C4IP Written Submission RE: Inv. No. 337-TA-1380,

03/13/2025

Resources:

Resources:

C4IP Comments RE: The Development of an Artificial Intelligence (AI) Action Plan (2025-02305),

03/11/2025

Resources:

Resources:

Joint High-Level Statement Valuing Creation, Invention, and Innovation: Re-booting Europe’s Potential,

11/07/2024

Resources:

Resources:

C4IP Comments RE: Experimental Use Exception Request for Comments (PTO-C-2024-0023),

09/26/2024

Resources:

Resources:

C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026),

09/16/2024

Scroll to Top